Meprosa en es it fr

Meprosa Brand names, Meprosa Analogs

Meprosa Brand Names Mixture

  • No information avaliable

Meprosa Chemical_Formula


Meprosa RX_link

No information avaliable

Meprosa fda sheet

Meprosa msds (material safety sheet)

Meprosa Synthesis Reference

No information avaliable

Meprosa Molecular Weight

309.469 g/mol

Meprosa Melting Point

< 25 oC

Meprosa H2O Solubility

Soluble as HCl salt

Meprosa State


Meprosa LogP


Meprosa Dosage Forms

Tablets (oral, 1 mg)

Meprosa Indication

Used for the symptomatic treatment of parkinsonism.

Meprosa Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Meprosa Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Meprosa side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Meprosa Patient Information

Meprosa Organisms Affected

Humans and other mammals